[Elsevier] Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies

Closed

daemiel Post time 6 day(s) ago | Show all posts |Read mode

Reward10points

journal：The Journal of Heart and Lung Transplantation

Authors：Jan M. Griffin; Eleonore Baughan; Hannah Rosenblum; Kevin J. Clerkin; Justin A. Fried; Jayant Raikhelkar; Nir Uriel; Thomas H. Brannagan; Koji Takeda; Justin L. Grodin; Charles Marboe; Mathew S. Maurer; Maryjane A. Farr

Published date：2022-2-

DOI：10.1016/j.healun.2021.10.007

PDF link：https://www.sciencedirect.com/sc ... 053249821025468/pdf

Article link：http://dx.doi.org/10.1016/j.healun.2021.10.007

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

daemiel Lv.2

Junior Member

post
reply
points
70

[Elsevier] Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies